The aim of the FOCUS project is to test the Fixed Dose Combination concept for cardiovascular
prevention in populations of different socio-economic characteristics. At the same time,
FOCUS aims to understand the factors determining inappropriate prescribing for secondary
cardiovascular prevention and those for poor patients adherence to treatment. This will allow
FOCUS to establish recommendations for a better use of medication in patients with ischemic
heart disease. In addition, after a successful completion of FOCUS, secondary prevention
medication will be available and affordable for a large number of patients in both developed
as well as developing countries.
There are two Phases in this study:
Phase 1: Is a descriptive, non interventional study. Phase 2: Is an interventional,
randomized trial with prospective economic evaluation.